Jon Olson, MD
Neurology · Baton Rouge, LANPI 1619966819
Payments from drug & device makers
Across 1,157 payments — averaging $1431.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$1.1M
- Sanofi$326K
- Genentech, Inc.$131K
- Novocure GmbH$120K
- AbbVie$3K
- Biogen$1K
- plus $14K from 49 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$1,656,304 in reported general payments places this provider in the 95th percentile of 225 neurology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology in Baton Rouge
- Kevin CallerameBaton Rouge$420K
- Gerald CaleganBaton Rouge$400K
- Benjamin KidderBaton Rouge$35K
- Joseph AcostaBaton Rouge$33K
- William GladneyBaton Rouge$19K
- David GlossBaton Rouge$15K
- Ariel Antezana AntezanaAlexandria$2.5M
- Bridget BagertNew Orleans$1.4M
- Carol RedillasChalmette$1.3M
- Joseph TarsiaNew Orleans$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.